UMB Bank’s Guardant Health GH Stock Holding History

UMB Bank’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.1K	Buy	+14	New	+$1.52K	﹤0.01%	2204
2023 Q4	–	Sell	-39	Closed	-$1.16K	–	1662
2023 Q3	$1.16K	Buy	+39	New	+$1.37K	﹤0.01%	1585

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

UMB Bank's GH Position: Q2 2026 in Review

UMB Bank opened a new position in Guardant Health (GH) in Q2 2026: 14 shares worth $2.1K. The stake represents ﹤0.01% of the portfolio and ranks #2204 among its holdings. This is a return to the name: UMB Bank previously reported a position in GH as recently as Q3 2023.

UMB Bank first reported a position in GH in Q3 2023 and has held it in 2 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

UMB Bank held 14 shares of Guardant Health worth $2.1K as of Q2 2026.
Guardant Health was a new UMB Bank position in Q2 2026.
Guardant Health made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2204 holding.
UMB Bank first reported a position in Guardant Health in Q3 2023 and has held it in 2 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.